Table 3 Occurrence of cardiopulmonary events during the follow-up period.
Outcomes | HF n = 46 | COPD n = 53 | HF + COPD n = 25 | p |
|---|---|---|---|---|
Disease exacerbation, n (%) | 16 (34.7) | 20 (37.7) | 10 (40) | 0.85 |
AMI, n (%) | 3 (6.5) | 0 (0) | 0 (0) | 0.07 |
Stroke, n (%) | 3 (6.9) | 4 (7.5) | 1 (4) | 0.97 |
Hospitalization, n (%) | 10 (21.7) | 13 (28.2) | 7 (15.2) | 0.40 |
Death, n (%) | 4 (6.5) | 5 (9.4) | 5 (16) | 0.59 |
Others, n (%) | 9 (19.6) | 4 (7.5) | 1 (4) | 0.07 |
